Menu
Meet the Program Commitee for DIA Japan 2023!
Program Committee
-
Koji Iwasaki, PhD • Professor, Academic Clinical Research Center,
Osaka University Hospital, Japan -
Yukihiro Matsuda, MSc • Director, Clinical Delivery
ICON Clinical Research GK, Japan -
Mayu Fujita • Senior Reviewer, Office of Pharmacovigilance l, office of new Drug l
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Yuko Hata • Associate director, Therapeutic Area Regulatory, Japan Regulatory Affairs
Takeda Pharmaceutical Company, Japan -
Yuki Kai, MBA • Clinical Strategy and Resource Management Department, Clinical Development Divis
Chugai Pharmaceutical Co., Ltd.,, Japan -
Yusuke Kajimoto • Senior Scientist, Scientific Affairs
MSD K.K., Japan -
Keiko Katsui, PhD • Group of Social Co-Creation
Japan Agency for Medical Research and Development (AMED), Japan -
Atsushi Kitamura, MS • Director, GCP Quality Japan
Pfizer R&D Japan G.K., Japan -
Naoki Kotani, PhD • Pharmaceutical Science Dept.
Chugai Pharmaceutical Co., Ltd., Japan -
Kana Maruyama • Manager, Regulatory Labeling, Regulatory Affairs
Viatris Pharmaceuticals Japan GK, Japan -
Takeshi Mikami • Sr. Statstical Prgrammer Analysit, SP&A
Janssen: Pharmaceutical Companies of Johnson & Johnson, Japan -
Hiroyuki Murakami • Duputy Review Director, Office of New Drug I
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Noriaki Nagao, MPharm, PMP • Pharmaceutical Division,Clinical Development Dept.
JAPAN TOBACCO INC., Japan -
Yukiko Nishimura, PhD, MSc • Director
Advocacy Service for Rare and Intractable Diseases, Japan -
Katsuhiko Sawada, MPharm • Director, Research and Development Dept.
Otsuka Medical Devices Co.Ltd., Japan -
Yasuharu Shibata, MSc • Head of Clinical Data Management, Cliinical Data Management
MSD K.K., Japan -
Yoshiyuki Sugimoto, PhD, RPh • Medical Affairs Manager, Medical Affairs, Dermatology, Immunology
Abbvie GK, Japan -
Keisuke Suzuki, PhD • Director, Innovation Center for Translational Research
National Center for Geriatrics and Gerontology, Japan -
Kazumi Taguchi, MSc • Discovery Accelerator,EIR Business Lead
Astellas Pharma, Japan -
Keiko Tsumori, MSc • Associate Director, Medical Writing, Regulatory Affairs Area, Japan Development
MSD K.K., Japan -
Taiji Yamasaki • Senior Director, Study Management
Merck & Co., Inc., Japan -
Motoki Arakawa, PhD • Junior Associate Professor, School of Pharmacy
Nihon University , Japan -
Katsuhiko Ichimaru • Review Director, Office of New Drug IV
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Mitsuo Ishikawa, MPharm •
Medii, Japan -
Jun Yamakami, PhD • Senior Manager, R&D Regulatory 1, Regulatory Affairs
Sanofi K.K., Japan -
Haruko Yamamoto, MD, PhD • Executive Director
National Cerebral and Cardiovascular Center, Japan -
Junichi Nishino, MSc, RPh • Head, Regulatory Affairs Department
Otsuka Pharmaceutical Co., Ltd., Japan -
Goshi Ozawa, MS • Representative Director & President, Japan / R&D Head
Juniper Therapeutix K.K., Japan -
Sonoko Misawa, MD, PhD • Associate Professor, Department of Neurology
Chiba University Graduate of Medicine, Japan -
Kazuhiko Ishida, MSc, RPh • Director, Pharmacovigilance
Astellas Pharma Inc., Japan -
Junko Sato, PhD • Associate Executive Director
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Soichiro Azumi • Associate Manager, R&D Quality Group
Daiichi Sankyo Co., Ltd., Japan -
Koichi GOTO • Deputy Manager
CM Plus Corporation, Japan -
Yuiko Kawauchi • Tsukuba Clinical Research & DevelopmentOrganization·Technical Staff
University of Tsukuba Hospital, Japan -
Toshifumi Sugizaki • Reviewer, Office of New Drug I
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Shogo Nakamori, MBA, MSc, RPh • Senior Vice President & Managing Director, DIA Japan, Korea, and Singapore
DIA, Japan